These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 8928847

  • 1. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
    Bech JN, Nielsen CB, Pedersen EB.
    Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
    [Abstract] [Full Text] [Related]

  • 2. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN, Nielsen EH, Pedersen RS, Svendsen KB, Pedersen EB.
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [Abstract] [Full Text] [Related]

  • 3. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.
    Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB.
    Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329
    [Abstract] [Full Text] [Related]

  • 4. Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study.
    Bech JN, Aagaard NK, Pedersen RS, Sorensen TB, Vilstrup H, Pedersen EB.
    Liver Int; 2014 Feb; 34(2):211-9. PubMed ID: 23809512
    [Abstract] [Full Text] [Related]

  • 5. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
    Berger ED, Bader BD, Rüb N, Rauscher MA, Rebenschütz I, Gaber OC, Enderle MD, Risler T, Erley CM.
    Kidney Blood Press Res; 2002 Feb; 25(1):42-9. PubMed ID: 11834876
    [Abstract] [Full Text] [Related]

  • 6. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis.
    Lahera V, Navarro J, Biondi ML, Ruilope LM, Romero JC.
    Am J Physiol; 1993 Feb; 264(2 Pt 2):F344-7. PubMed ID: 8383451
    [Abstract] [Full Text] [Related]

  • 7. Physiological role of nitric oxide in regulation of renal function in humans.
    Haynes WG, Hand MF, Dockrell ME, Eadington DW, Lee MR, Hussein Z, Benjamin N, Webb DJ.
    Am J Physiol; 1997 Mar; 272(3 Pt 2):F364-71. PubMed ID: 9087680
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nitric oxide synthesis inhibition does not impair water immersion-induced renal vasodilation in humans.
    Dijkhorst-Oei LT, Boer P, Rabelink TJ, Koomans HA.
    J Am Soc Nephrol; 2000 Jul; 11(7):1293-1302. PubMed ID: 10864586
    [Abstract] [Full Text] [Related]

  • 10. Assessment of endothelial function of the renal vasculature in human subjects.
    Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE.
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of renal interstitial hydrostatic pressure in natriuresis of systemic nitric oxide inhibition.
    Haas JA, Khraibi AA, Perrella MA, Knox FG.
    Am J Physiol; 1993 Mar; 264(3 Pt 2):F411-4. PubMed ID: 8456954
    [Abstract] [Full Text] [Related]

  • 13. Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats.
    Kvam FI, Ofstad J, Iversen BM.
    Kidney Blood Press Res; 2000 Mar; 23(6):376-84. PubMed ID: 11070417
    [Abstract] [Full Text] [Related]

  • 14. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
    Nielsen CB, Bech JN, Pedersen EB.
    Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
    [Abstract] [Full Text] [Related]

  • 15. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
    Eiskjaer H, Pedersen EB.
    Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
    [Abstract] [Full Text] [Related]

  • 16. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
    Schmidt A, Bayerle-Eder M, Pleiner H, Zeisner C, Wolzt M, Mayer G, Schmetterer L.
    Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
    [Abstract] [Full Text] [Related]

  • 17. Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment.
    Tietze IN, Sørensen SS, Ivarsen PR, Nielsen CB, Pedersen EB.
    J Hypertens; 1997 May; 15(5):551-60. PubMed ID: 9170009
    [Abstract] [Full Text] [Related]

  • 18. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
    Larsen T, Mose FH, Bech JN, Pedersen EB.
    Clin Exp Hypertens; 2012 May; 34(8):567-74. PubMed ID: 22559218
    [Abstract] [Full Text] [Related]

  • 19. Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.
    Al Therwani S, Malmberg MES, Rosenbaek JB, Bech JN, Pedersen EB.
    BMC Nephrol; 2017 Aug 15; 18(1):268. PubMed ID: 28810844
    [Abstract] [Full Text] [Related]

  • 20. Renal and hormonal effects of systemic nitric oxide inhibition in patients with congestive heart failure and in healthy control subjects.
    Bech JN, Starklint J, Bentzen H, Nyvad O, Pedersen EB.
    J Card Fail; 2013 Nov 15; 19(11):776-85. PubMed ID: 24263123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.